European Pharmacopoeia -ph. Eur.- Monograph Tablets -0478- May 2026

Understanding Ph. Eur. Monograph 0478: The Standard for Tablets

Guide to Ph. Eur. Monograph 0478: Tablets

1. Introduction

Monograph 0478, Tablets, is a general monograph in the European Pharmacopoeia (Ph. Eur.) that lays down mandatory quality standards for all solid oral dosage forms defined as tablets. It applies to uncoated, film-coated, and sugar-coated tablets, unless otherwise specified in an individual monograph. European Pharmacopoeia -ph. Eur.- Monograph Tablets -0478-

• Appropriate primary/secondary packaging to maintain product quality; label must state batch number, expiry, storage conditions, and dosing instructions.

The monograph outlines several critical tests to ensure every batch is safe and effective: Understanding Ph

• When applicable (e.g., chewable, effervescent), disintegration testing per general monograph; faster disintegration may be required for certain immediate-release products.

The monograph prescribes several standard tests to ensure batch-to-batch consistency and patient safety: Revised Ph. Eur. Chapter Tablets - ECA Academy The monograph outlines several critical tests to ensure

• Loss ≤ 1.0% (for conventional tablets).
• For tablets with a weight ≥ 650 mg, or for compressed lozenges, ≤ 0.5%.
• Cracked, cleaved, or broken tablets: Automatic failure (even if weight loss < 1%).

Mechanical Strength: While not always mandatory for final release, tests for Friability (2.9.7) and Resistance to Crushing (2.9.8) are used during production to ensure tablets don't crumble during handling. Recent Regulatory Updates

Effervescent Tablets: Designed to dissolve in water with the release of carbon dioxide.